ErbB2 Immune Response in Breast Cancer Patients with Soluble Receptor Ectodomain
- 30 April 2000
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (4) , 1417-1424
- https://doi.org/10.1016/s0002-9440(10)65010-9
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Immune responses to all ErbB family receptors detectable in serum of cancer patientsOncogene, 1999
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patientsEuropean Journal Of Cancer, 1996
- Fas ligation induces apoptosis of CD40-activated human B lymphocytes.The Journal of Experimental Medicine, 1995
- Induction of anti-self-immunity to cure cancerCell, 1995
- Immunity to Oncogenic ProteinsImmunological Reviews, 1995
- The biology of erbB-2/nue/HER-2 and its role in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984